Investigating the impact of added Profhilo mesogel to subcision versus subcision monotherapy in treating acne scars; a single‐blinded, split‐face randomized trial
Journal of Cosmetic Dermatology · 2024
DOI: 10.1111/jocd.16258 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cosmetic Dermatology, 2024. Verfasst von Mani Dastgheib und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Acne Vulgaris, Cicatrix, Hyaluronic Acid, Patient Satisfaction. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tehran University of Medical Sciences and Health Services.
Abstract (Originalsprache)
Background
Acne scar is an inflammatory condition, which commonly occurs in patients with acne vulgaris, especially in adults. Mesogels have been reported effective in improving atrophic acne scars.
Aims
We investigated the efficacy of adding Profhilo (a hyaluronic acid‐based filler) to subcision as a new treatment method.
Methods
Twelve patients aged 18–45 years with atrophic acne scars on both sides of the face participated in this single‐blinded, split‐face, randomized controlled trial. Each side of the face was randomly assigned to one of the treatment methods, including subcision alone and subcision + Profhilo. Patients in the Profhilo arm received mesogel (1 cc) in addition to the subcision procedure. Both methods were carried out two times at 1‐month intervals. Assessments were done based on the sonographic depth of scars, and two blinded observers examined photographs at baseline and 3 months after the final session and the results were reported based on an exclusively made formula as the total score. The Global Improvement Scale and Visual Analogue Scale (VAS) (for patient satisfaction) were also used.
Results
The VAS score of patient satisfaction was statistically significant in the Profhilo arm, with a mean improvement of 528.08 and 219.06 in the subcision arm ( p = 0.02). No significant difference was seen in total acne scar reduction comparing the two methods (29.74 in the Profhilo arm and 22.27 in the subcision arm, p = 0.56). Sonographic depth reduction was also non‐significant, with a mean of 29.21 in the Profhilo arm and 28.53 in the subcision arm ( p = 0.4). The mean global improvement was reported as four in both arms, and no statistical significance was observed ( p = 0.89). The best response to treatment belonged to the rolling subtype in both methods ( p = 0.029 for the Profhilo arm and p = 0.001 for the subcision arm).
Conclusion
Despite no significant difference between the methods, Profhilo is more effective due to a higher satisfaction rate and better physiologic effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.
- Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
- Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Mani Dastgheib, Sama Heidari, Arghavan Azizipour, Mohammadreza Kavyani, Vahide Lajevardi, Amir Hooshang Ehsani, Amir Teimourpour, Maryam Daneshpazhooh, Mansour Nassiri Kashani, Kamran Balighi
Förderung
- Tehran University of Medical Sciences and Health Services
Zitieren
APA
Dastgheib, M., Heidari, S., Azizipour, A., Kavyani, M., Lajevardi, V., Ehsani, A. H., Teimourpour, A., Daneshpazhooh, M., Kashani, M. N., & Balighi, K. (2024). Investigating the impact of added Profhilo mesogel to subcision versus subcision monotherapy in treating acne scars; a single‐blinded, split‐face randomized trial. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.16258
Vancouver
Dastgheib M, Heidari S, Azizipour A, Kavyani M, Lajevardi V, Ehsani AH, et al. Investigating the impact of added Profhilo mesogel to subcision versus subcision monotherapy in treating acne scars; a single‐blinded, split‐face randomized trial. Journal of Cosmetic Dermatology. 2024. doi:10.1111/jocd.16258
BibTeX
@article{Dastgheib2024,
author = {Dastgheib, Mani and Heidari, Sama and Azizipour, Arghavan and Kavyani, Mohammadreza and Lajevardi, Vahide and Ehsani, Amir Hooshang and Teimourpour, Amir and Daneshpazhooh, Maryam and Kashani, Mansour Nassiri and Balighi, Kamran},
title = {Investigating the impact of added Profhilo mesogel to subcision versus subcision monotherapy in treating acne scars; a single‐blinded, split‐face randomized trial},
journal = {Journal of Cosmetic Dermatology},
year = {2024},
doi = {10.1111/jocd.16258}
}
EUVIMED